Efficacy and safety of once‐weekly subcutaneous semaglutide on weight loss in patients with overweight or obesity without diabetes mellitus—A systematic review and meta‐analysis of randomized controlled trials
Article in Obesity Reviews (June 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in Obesity Reviews (June 2024)
Article in BMJ Open (June 2024)
Article in Experimental and Clinical Endocrinology & Diabetes (June 2024)